The global Network Point-of-Care Glucose Testing Market, valued at USD 1.8 billion in 2025, is projected to reach USD 2.9 billion by 2035, expanding at a compound annual growth rate (CAGR) of 4.8% over the forecast period, according to a new market outlook. The surge is driven by the increasing prevalence of diabetes, the need for decentralized diagnostics, and the integration of connected healthcare infrastructure.
Key Market Highlights
- 2025 Market Value: USD 1.8 billion
- 2035 Forecast Value: USD 2.9 billion
- CAGR (2025–2035): 4.8%
- Leading Product Segment (2025): i-STAT (36.7%)
- Top Growth Regions: North America, Asia-Pacific, and Europe
- Key Players: Abbott, Roche, Danaher, Nipro, Platinum Equity Advisors, Nova Biomedical, ACON Laboratories, Bayer AG/Ascensia Diabetes Care, Trividia Health, Prodigy Diabetes Care, EKF Diagnostics
Growth Drivers: Diabetes Epidemic and Digital Health Integration
With 422 million people worldwide living with diabetes (WHO), the demand for faster, more connected glucose testing solutions is increasing sharply. Traditional laboratory testing often causes treatment delays, while network point-of-care glucose testing (POC-GT) delivers near-instant results at the patient’s side, reducing turnaround times and enabling timely interventions.
Click Here for More Information:- https://www.futuremarketinsights.com/reports/network-point-of-care-glucose-testing-market
The integration of wireless communication, cloud platforms, and electronic medical records (EMR) has positioned POC-GT as a cornerstone of modern chronic disease management. These systems not only improve patient outcomes but also support healthcare providers in data-driven decision-making and coordinated care delivery.
Market Segmentation: i-STAT Leads the Pack
By product type, i-STAT dominates with a 36.7% revenue share in 2025, owing to its multifunctional diagnostics, compact design, and strong interoperability with hospital information systems. Its widespread adoption in emergency and critical care units underscores its role in accelerating diagnostic workflows.
Other significant product lines include Accu-Chek Inform II, Stat Strip, Hemo Cue, and Care Sens Expert Plus, each demonstrating growth as hospitals and clinics expand decentralized care capabilities. Notably, Accu-Chek Inform II has sustained historical CAGR growth of 4.5% (2020–2024) and is expected to accelerate to 4.9% (2025–2035).
Regional Outlook: North America and Asia-Pacific Drive Expansion
North America remains the largest market, growing at 4.9% CAGR from 2025–2035. Strong government initiatives, broad adoption of digital health platforms, and leadership from major players such as Abbott, Roche, and Nova Biomedical fuel this dominance. In the U.S. alone, diabetes affects 11.3% of the population, highlighting urgent demand for POC testing.
Asia-Pacific represents the fastest-growing region, with over 90 million adults currently diabetic, a figure expected to reach 152 million by 2045 (IDF). Countries such as China, India, and Indonesia face high rates of undiagnosed cases, spurring government-backed initiatives to expand POC testing in both urban and rural healthcare settings.
Europe continues to play a pivotal role, with increasing adoption of hospital-based POC systems and favorable reimbursement policies supporting expansion.
Competitive Landscape: Innovation and Strategic Partnerships
The competitive landscape is defined by product innovation and global expansion strategies.
- Roche launched its Cobas Pulse system (Jan 2025), designed as the first diagnostic tool at the point of care to integrate seamlessly with digital health applications.
- EKF Diagnostics introduced the STAT-Site WB handheld analyzer (Oct 2024), enabling glucose and β-ketone readings in seconds.
- ACON Laboratories expanded its U.S. portfolio with the On Call Express Voice system (Sept 2020), adding audio-guided glucose monitoring for improved patient usability.
- Abbott continues to dominate with its FreeStyle Libre 2 integrated CGM system, enhancing patient engagement through mobile app integration.
These developments underscore a strategic industry shift toward connected, user-friendly, and data-enabled POC testing devices.
Market Positioning: From Diagnostics to Preventive Care
The Network POC Glucose Testing Market is positioned at the intersection of diagnostics, chronic disease management, and digital health transformation. Beyond glucose measurement, these systems are increasingly valued for their role in remote monitoring, predictive analytics, and preventive healthcare pathways.
With diabetes ranking as the ninth leading cause of death globally, and nearly 1 in 2 patients undiagnosed (IDF 2024), the need for rapid, reliable, and accessible POC testing solutions has never been greater. The expansion into low- and middle-income countries will be a critical factor in shaping the market’s trajectory over the next decade.
Get Sample Report: – https://www.futuremarketinsights.com/reports/sample/rep-gb-15860
Outlook
The Network Point-of-Care Glucose Testing Market is set for sustained growth as healthcare systems worldwide embrace decentralized, patient-centric diagnostics. With strong market leadership from i-STAT, emerging innovations from Roche, Abbott, and EKF, and rising adoption across North America and Asia-Pacific, the industry is moving beyond traditional glucose monitoring toward an integrated, connected care ecosystem.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
